Development of simulated intestinal fluids containing nutrients as transport media in the Caco-2 cell culture model:: Assessment of cell viability, monolayer integrity and transport of a poorly aqueous soluble drug and a substrate of efflux mechanisms

被引:50
作者
Lind, Marianne L. [1 ]
Jacobsen, Jette [1 ]
Holm, Rene [2 ]
Mullertz, Anette [1 ]
机构
[1] Univ Copenhagen, Fac Pharmaceut Sci, Dept Pharmaceut Analyt Chem, DK-2100 Copenhagen, Denmark
[2] Preformulat, DK-2500 Valby, Denmark
关键词
Caco-2 cell culture; intestinal absorption; transport medium; simulated intestinal fluid;
D O I
10.1016/j.ejps.2007.08.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to identify simulated intestinal fluids (SIFs) containing nutrients compatible with the Caco-2 cell culture model and to examine the impact of the identified medium on the transport of a poorly aqueous soluble model compound, estradiol, and a substrate of efflux mechanisms, etoposide. Monolayer integrity was evaluated by transepithelial electrical resistance and cellular viability by release of lactate dehydrogenase to the apical compartment and cellular protein content. It was shown that the viability of Caco-2 cells was enhanced by use of the CO2 independent nutritional medium, Leibovitz's L-15 compared to Hanks' balanced salt solution. SIF containing 5 mM sodium taurocholate and 1.25 mM phosphatidylcholine or lysophosphatidylcholine in Leibovitz's L-15 induced less release of lactate dehydrogenase than the traditional transport medium, HBSS. Addition of lipolysis products, 0.5 mM oleic acid and 0.25 mM monoolein, did only cause increase in lactate dehydrogenase in 3 of 12 comparisons. The presence of SIFs in the apical compartment was shown to decrease flux of estradiol due to incorporation of estradiol in micelles and hence a decreased fraction of free estradiol. Further, a concentration dependent increase in the apparent permeability of etoposide was observed from apical to basolateral compartment, which indicated that components in the SIFs affects efflux mechanisms. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:261 / 270
页数:10
相关论文
共 38 条
[21]   Inhibitory effect of a bitter melon extract on the P-glycoprotein activity in intestinal Caco-2 cells [J].
Konishi, T ;
Satsu, H ;
Hatsugai, Y ;
Aizawa, K ;
Inakuma, T ;
Nagata, S ;
Sakuda, S ;
Nagasawa, H ;
Shimizu, M .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 143 (03) :379-387
[22]   AN ENZYME-RELEASE ASSAY FOR NATURAL CYTO-TOXICITY [J].
KORZENIEWSKI, C ;
CALLEWAERT, DM .
JOURNAL OF IMMUNOLOGICAL METHODS, 1983, 64 (03) :313-320
[23]   GROWTH AND MAINTENANCE OF TISSUE-CELL CULTURES IN FREE GAS EXCHANGE WITH ATMOSPHERE [J].
LEIBOVIT, A .
AMERICAN JOURNAL OF HYGIENE, 1963, 78 (02) :173-&
[24]   Characterization of fluids from the stomach and proximal jejunum in men and women [J].
Lindahl, A ;
Ungell, AL ;
Knutson, L ;
Lennernas, H .
PHARMACEUTICAL RESEARCH, 1997, 14 (04) :497-502
[25]   ISOLATION AND PROPERTIES OF MIXED LIPID MICELLES PRESENT IN INTESTINAL CONTENT DURING FAT DIGESTION IN MAN [J].
MANSBACH, CM ;
COHEN, RS ;
LEFF, PB .
JOURNAL OF CLINICAL INVESTIGATION, 1975, 56 (04) :781-791
[26]   MEMBRANE DAMAGE BY BILE-SALTS - THE PROTECTIVE FUNCTION OF PHOSPHOLIPIDS [J].
MARTIN, GP ;
MARRIOTT, C .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1981, 33 (12) :754-759
[27]   BILE SALT-INDUCED AND LYSOPHOSPHATIDYLCHOLINE-INDUCED MEMBRANE DAMAGE IN HUMAN ERYTHROCYTES [J].
MARTIN, GP ;
ELHARIRI, LM ;
MARRIOTT, C .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1992, 44 (08) :646-650
[28]   A comparison of the permeation enhancement potential of simple bile salt and mixed bile salt:fatty acid micellar systems using the CaCo-2 cell culture model [J].
Meaney, CM ;
O'Driscoll, CM .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 207 (1-2) :21-30
[29]   Transepithelial electrical resistance is not a reliable measurement of the Caco-2 monolayer integrity in Transwell [J].
Mukherjee, T ;
Squillantea, E ;
Gillespieb, M ;
Shao, J .
DRUG DELIVERY, 2004, 11 (01) :11-18
[30]   Use of simulated intestinal fluids with Caco-2 cells in rat ileum [J].
Patel, N ;
Forbes, B ;
Eskola, S ;
Murray, J .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2006, 32 (02) :151-161